Author:
Miller W R,Stuart M,Sahmoud T,Dixon J M
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Anderson TJ, Dixon JM, Stuart M, Sahmoud T, Miller WR (2000) Effect of neoadjuvant treatment with anastrozole (‘Arimidex’) on pathological markers of tumors in post-menopausal women with large operable breast cancer. Am Assoc Cancer Res 41: 741
2. Bajetta E, Zilembo N, Bichisao E (1999) Aromatase inhibitors in the treatment of postmenopausal breast cancer. Drugs Aging 15: 271–283
3. Bonneterre J, Thurlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler (2000) Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women – results of the Tamoxifen or Arimidex™ Randomized Group Efficacy and Tolerability study. J Clin Oncol 18: 3748–3757
4. Buzdar A, Nabholtz JM, Robertson JF, Thurlimann B, Bonneterre J, von Euler M, Steinberg M, Webster A (2000) Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer (abc) in postmenopausal (pm) women – combined analysis from two identically designed multicenter trials. Proc ASCO 19: 154a (Abstract 609D)
5. Buzdar AU, Jonat W, Howell A, Jones SE, Blomqvist CP, Vogel CL, Eiermann W, Wolter JM, Steinberg M, Webster A, Lee D (1998) Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma. Results of a survival update based on a combined analysis of data from two mature Phase III trials. Arimidex Study Group. Cancer 83: 1142–1152
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献